Based on the key indicators obtained from Alcon AG's historical financial statements, Alcon AG is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December. At present, Alcon AG's Net Debt is projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 1.2 B, whereas Total Assets are forecasted to decline to about 24.5 B. Key indicators impacting Alcon AG's financial strength include:
Investors should never underestimate Alcon AG's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Alcon AG's cash flow, debt, and profitability to make informed and accurate decisions about investing in Alcon AG.
Net Income
1.02 Billion
Alcon
Select Account or Indicator
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Dividends Paid
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Net Borrowings
Total Cashflows From Investing Activities
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Investments
Sale Purchase Of Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Good Will
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Short Term Debt
Intangible Assets
Short Term Investments
Other Assets
Accumulated Other Comprehensive Income
Other Liab
Net Tangible Assets
Property Plant Equipment
Long Term Debt Total
Capital Lease Obligations
Deferred Long Term Liab
Net Invested Capital
Long Term Investments
Property Plant And Equipment Gross
Short Long Term Debt
Non Current Liabilities Other
Net Working Capital
Long Term Debt
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Depreciation And Amortization
Ebitda
Tax Provision
Interest Income
Selling General Administrative
Net Income Applicable To Common Shares
Net Interest Income
Net Income From Continuing Ops
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Alcon AG Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Alcon AG's financial statements are interrelated, with each one affecting the others. For example, an increase in Alcon AG's assets may result in an increase in income on the income statement.
Please note, the presentation of Alcon AG's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Alcon AG's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Alcon AG's management manipulating its earnings.
Alcon AG Stock Summary
Alcon AG competes with Nexgel, Avinger, Sharps Technology, Microbot Medical, and Pro Dex. Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland. Alcon operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 24000 people.
Comparative valuation techniques use various fundamental indicators to help in determining Alcon AG's current stock value. Our valuation model uses many indicators to compare Alcon AG value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alcon AG competition to find correlations between indicators driving Alcon AG's intrinsic value. More Info.
Alcon AG is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Alcon AG is roughly 2.19 . At present, Alcon AG's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alcon AG's earnings, one of the primary drivers of an investment's value.
Alcon AG Systematic Risk
Alcon AG's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Alcon AG volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Alcon AG correlated with the market. If Beta is less than 0 Alcon AG generally moves in the opposite direction as compared to the market. If Alcon AG Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Alcon AG is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Alcon AG is generally in the same direction as the market. If Beta > 1 Alcon AG moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Alcon AG Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alcon AG's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Alcon AG growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.23
At present, Alcon AG's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
Alcon AG November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Alcon AG help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alcon AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alcon AG based on widely used predictive technical indicators. In general, we focus on analyzing Alcon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alcon AG's daily price indicators and compare them against related drivers.
When running Alcon AG's price analysis, check to measure Alcon AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alcon AG is operating at the current time. Most of Alcon AG's value examination focuses on studying past and present price action to predict the probability of Alcon AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alcon AG's price. Additionally, you may evaluate how the addition of Alcon AG to your portfolios can decrease your overall portfolio volatility.